Last $11.05 USD
Change Today +0.08 / 0.73%
Volume 262.7K
As of 4:00 PM 05/23/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas E. D'Ambra Ph.D.

Co-Founder, Chairman, Chief Executive Officer and President, Albany Molecular Research Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 3 different organizations across 3 different industries.

See Board Relationships
56$4,090,123
As of Fiscal Year 2012

Background*

Dr. Thomas E. D'Ambra, Ph.D. co-founded Albany Molecular Research Inc. in 1991 and has been its Chairman and Chief Executive Officer since 1991. Dr. D'Ambra has been the President at Albany Molecular Research Inc., since February 2003. He served as President of Molecular Research Inc., from 1991 to 1998. He co founded Coromed Inc., and served as its Vice President of Chemistry from 1989 to 1991. He served as Group Leader and Senior Research Chemist of Sterling Winthrop ...

Read Full Background

Corporate Headquarters*

21 Corporate Circle
Albany, New York 12203

United States

Phone: 518-512-2000
Fax: 518-512-2020

Board Members Memberships*

Director
1991-Present
Co-Founder, Chairman, Chief Executive Officer and President

Education*

BA
College of the Holy Cross
PhD
Massachusetts Institute of Technology

Other Affiliations*

Annual Compensation*

Salary$414,615
Total Annual Compensation$414,615

Stock Options*

Restricted Stock Awards$78,131
All Other Compensation$3,180,407
Unexercisable Options140,000
Unexercisable Options Value$189,800
Total Value of Options$189,800
Total Number of Options140,000

Total Compensation*

Total Annual Cash Compensation$3,896,792
Total Short Term Compensation$414,615
Other Long Term Compensation$3,258,538
Total Calculated Compensation$4,090,123
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRI:US $11.05 USD +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James C. Mullen Chief Executive Officer and Director
Patheon Inc.
$1.9M
Richard Ridinger Chief Executive Officer
Lonza Group AG
--
Masayo Tada Chief Executive Officer, President, Director and Chairman of Risk Management Committee
Dainippon Sumitomo Pharma Co., Ltd.
--
Kallam Satish Reddy B.Tech., M.S.Vice-Chairman, Managing Director, Chief Operating Officer, Member of The Management Council, Chairman of Management Committee and Member of Investment Committee
Dr. Reddy's Laboratories Ltd.
3.0M
Chidi Okoro Chief Executive Officer, Managing Director, Director, Member of Finance Committee and Member of Administrative Committee
GlaxoSmithKline Consumer Nigeria Plc
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALBANY MOLECULAR RESEARCH, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.